President Donald Trump announced Thursday that brand-name or patented pharmaceutical products will be subject to a 100% tariff starting Oct. 1 unless the pharmaceutical company is building a ...

ICH stability chambers with continuous monitoring for long-term, intermediate, and accelerated studies supporting FDA ...

In 2025, U.S. had a $112 billion pharmaceutical trade deficit, largely with Ireland and Switzerland. Trump suggested imposing 100% tariffs on certain pharmaceutical imports to reduce this deficit.

The U.S. will impose a 100% tariff on "all any branded or patented Pharmaceutical Product" entering the country from Oct. 1. The measure will not apply to companies building drug manufacturing plants ...

In 2025, the search for innovative pharmaceutical compounds with adaptive performance properties is accelerating. Among the many contenders, Healthletic has positioned itself prominently in the ...

When nearly 20 years ago, the Food and Drug Administration (FDA) issued a new rule 1 that pharmaceutical manufacturers must include a linear bar code on all immediate drug packages that included each ...

NORTHVALE, NJ / ACCESSWIRE / December 12, 2023 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing niche generic products, today ...

The Trump Administration has implemented or proposed a broad range of tariffs, including on pharmaceuticals. These tariffs are intended to serve as a bargaining chip with other countries, promote ...

LGM Pharma, a leading provider of tailored API sourcing, contract analytical testing, and CDMO services for the full drug ...